TTNP
Titan Pharmaceuticals
TTNP
TTNP
Delisted
TTNP was delisted on the 1st of October, 2025.
24 hedge funds and large institutions have $3.55M invested in Titan Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 9 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
89% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 9
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Holders
24
Holding in Top 10
–
Calls
–
Puts
$1K
Top Buyers
| 1 | +$284K | |
| 2 | +$27K | |
| 3 | +$23K | |
| 4 |
CCB
Cutter & Co Brokerage
Ballwin,
Missouri
|
+$18K |
Top Sellers
| 1 | -$467K | |
| 2 | -$341K | |
| 3 | -$195K | |
| 4 |
ECM
Element Capital Management
New York
|
-$156K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$136K |